Literature DB >> 18845647

FOXO3a: a novel player in thyroid carcinogenesis?

Stefan Karger1, Carl Weidinger, Kerstin Krause, Sien-Yi Sheu, Thomas Aigner, Oliver Gimm, Kurt-Werner Schmid, Henning Dralle, Dagmar Fuhrer.   

Abstract

The forkhead box transcription factor FOXO3a has recently been identified as central mediator of the cellular response to oxidative stress inducing cell cycle arrest or apoptosis. The aim of our study was to investigate the regulation of FOXO3a in the thyroid and to determine whether alterations in FOXO3a activity occur in thyroid carcinogenesis. In vitro, we demonstrate that FOXO3a activity is negatively regulated by the PI3K/Akt cascade promoting increased phosphorylation and cytoplasmatic accumulation of FOXO3a with decreased transcription of the target genes p27kip (CDKN1B) and Bim (BCL2L11), but increased expression of GADD45A. By contrast, we show that H(2)O(2) exposure activates FOXO3a in thyrocytes with JNK (MAPK8)-mediated nuclear accumulation of FOXO3a and increased expression of the cell cycle arrest genes p27kip and GADD45A. In vivo, we observed a marked cytoplasmatic accumulation of FOXO3a in differentiated thyroid cancers versus an exclusive nuclear accumulation in follicular adenoma and normal thyroid tissue. Moreover, this cytosolic accumulation of FOXO3a correlated with an increased phospho-Akt expression in thyroid malignancies and was accompanied by decreased expression of the FOXO targets p27kip and Bim and an increase in GADD45A mRNA expression in the thyroid cancers. Our data suggest FOXO3a as a novel player of cellular stress response in the thyroid, mediating the thyrocyte's fate either to survive or to undergo apoptosis. Furthermore, PI3K-dependent FOXO3a inactivation may be a novel pathomechanism for the escape from apoptosis in thyroid cancer cells, in particular in follicular thyroid carcinoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18845647     DOI: 10.1677/ERC-07-0283

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  26 in total

1.  Insulin glargine and insulin have identical effects on proliferation and phosphatidylinositol 3-kinase/AKT signalling in rat thyrocytes and human follicular thyroid cancer cells.

Authors:  K Müller; C Weidinger; D Führer
Journal:  Diabetologia       Date:  2010-02-24       Impact factor: 10.122

2.  Expression and prognosis of FOXO3a and HIF-1α in nasopharyngeal carcinoma.

Authors:  Zhu Shou; Li Lin; Jia Liang; Jing-Li Li; Hong-Yan Chen
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-31       Impact factor: 4.553

3.  FOXO1 controls thyroid cell proliferation in response to TSH and IGF-I and is involved in thyroid tumorigenesis.

Authors:  Miguel A Zaballos; Pilar Santisteban
Journal:  Mol Endocrinol       Date:  2012-11-16

4.  Foxo3a drives proliferation in anaplastic thyroid carcinoma through transcriptional regulation of cyclin A1: a paradigm shift that impacts current therapeutic strategies.

Authors:  Laura A Marlow; Christina A von Roemeling; Simon J Cooper; Yilin Zhang; Stephen D Rohl; Shilpi Arora; Irma M Gonzales; David O Azorsa; Honey V Reddi; Han W Tun; Heike R Döppler; Peter Storz; Robert C Smallridge; John A Copland
Journal:  J Cell Sci       Date:  2012-06-20       Impact factor: 5.285

5.  Proteasome inhibitor MG132 induces thyroid cancer cell apoptosis by modulating the activity of transcription factor FOXO3a.

Authors:  Wei Qiang; Fang Sui; Jingjing Ma; Xinru Li; Xiaojuan Ren; Yuan Shao; Jiazhe Liu; Haixia Guan; Bingyin Shi; Peng Hou
Journal:  Endocrine       Date:  2017-02-20       Impact factor: 3.633

6.  Microarray analysis of papillary thyroid cancers in Korean.

Authors:  Hyun Sook Kim; Do Hyung Kim; Ji Yeon Kim; Nam Ho Jeoung; In Kyu Lee; Jin Gu Bong; Eui Dal Jung
Journal:  Korean J Intern Med       Date:  2010-11-27       Impact factor: 2.884

Review 7.  PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas.

Authors:  Zahra Nozhat; Mehdi Hedayati
Journal:  Mol Diagn Ther       Date:  2016-02       Impact factor: 4.074

8.  Deregulation of FOXO3A during prostate cancer progression.

Authors:  Sanjeev Shukla; Meenakshi Shukla; Gregory T Maclennan; Pingfu Fu; Sanjay Gupta
Journal:  Int J Oncol       Date:  2009-06       Impact factor: 5.650

9.  The essential role of FoxO6 phosphorylation in aging and calorie restriction.

Authors:  Dae Hyun Kim; Min Hi Park; Ki Wung Chung; Min Jo Kim; Yu Ri Jung; Ha Ram Bae; Eun Ji Jang; Jun Sik Lee; Dong Soon Im; Byung Pal Yu; Hae Young Chung
Journal:  Age (Dordr)       Date:  2014-07-10

Review 10.  [Genetics of thyroid nodules and thyroid carcinoma].

Authors:  D Führer
Journal:  Internist (Berl)       Date:  2018-07       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.